We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Laser-Based Tool Injects Nanoparticles and Macromolecules into Cells with Minimal Damage

By LabMedica International staff writers
Posted on 29 Apr 2015
Print article
Image: BLAST drives nanoparticles, enzymes, antibodies, and bacteria into cells at the rate of 100,000 cells per minute—significantly faster than current technology (Photo courtesy of UCLA - University of California, Los Angeles).
Image: BLAST drives nanoparticles, enzymes, antibodies, and bacteria into cells at the rate of 100,000 cells per minute—significantly faster than current technology (Photo courtesy of UCLA - University of California, Los Angeles).
Cell biologists have developed a laser-based tool that is capable of injecting large objects such as nanoparticles, bacteria, or macromolecules into cells at a speed much greater than allowed by current technologies.

Investigators at the University of California, Los Angeles (USA) call the new tool "biophotonic laser-assisted surgery tool (BLAST)." BLAST is, in essence, a silicon chip with an array of micrometer-wide holes, each surrounded by an asymmetric, semicircular coating of titanium.

A reservoir of liquid that includes the particles to be delivered is located beneath the holes. Target cells are loaded onto the silicon chip, and a laser pulse is used to heat the titanium coating, which instantly boils the water layer adjacent to parts of the cell. This generates an array of microcavitation bubbles that form pores in adjacent cell membranes through which cargo is gently driven by pressurized flow.

The investigators reported in the April 6, 2015, online edition of the journal Nature Methods that the platform delivered large items including bacteria, enzymes, antibodies, and nanoparticles into diverse cell types with high efficiency—up to 100,000 cells per minute—and cell viability.

“The new information learned from these types of studies could assist in identifying pathogen targets for drug development, or provide fundamental insight on how the pathogen–host interaction enables a productive infection or effective cellular response to occur,” said contributing author Dr. Michael Teitell, professor of pediatric and developmental pathology at the University of California, Los Angeles.

Related Links:

University of California, Los Angeles


New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit
New
Newborn Screening Test
NeoMass AAAC 3.0

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.